Evaluating Prescriptions, Prescription Processing, and Compounding Calculations

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/26

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary flashcards covering prescription processing, legal prescribing authority, controlled substance red flags, patient care frameworks, and compounding terms based on lecture notes.

27 Terms

1
New cards

Prescription

A legal order and document governed by federal and state law that serves as the communication mechanism authorizing a pharmacist to dispense medication.

2
New cards

Corresponding Responsibility

The legal rule under 21 CFR 1306.04(a) establishing that while a prescriber is responsible for properly issuing a controlled substance prescription, a corresponding responsibility rests on the pharmacist who fills it.

3
New cards

The Joint Commission (JC)

An organization that sets healthcare patient-safety standards, accredits and certifies healthcare programs, and documents findings of noncompliance if facilities use unsafe medical abbreviations.

4
New cards

Dispense as Written (DAW)

A standardized set of numerical codes used on prescriptions to specify whether a generic product or biosimilar may be substituted for a brand-name product.

5
New cards

DAW 1

The code used when generic substitution is prohibited because the prescriber explicitly requests the brand-name product on the prescription.

6
New cards

DAW 2

The code used when generic substitution is allowed by the prescriber, but the patient specifically requests the brand-name product.

7
New cards

DAW 9

The code used when the patient's insurance plan requires dispensing the brand-name product over the generic.

8
New cards

Beyond-Use Date (BUD)

The date assigned by a pharmacist after which a dispensed, reconstituted, repackaged, or compounded medication should no longer be used by the patient.

9
New cards

Expiration Date

The date established by the manufacturer on the original container based on long-term stability testing, assuming the product remains sealed and stored correctly.

10
New cards

National Provider Identifier (NPI)

A unique identification number issued by the Centers for Medicare & Medicaid Services (CMS) to identify healthcare providers for billing purposes.

11
New cards

DEA Number

A unique registration identifier issued by the Drug Enforcement Administration to entities authorized to handle controlled substances.

12
New cards

Full Prescribing Authority

The broad prescribing scope granted to Medical Doctors (MD) and Doctors of Osteopathy (DO) to diagnose and treat human disease.

13
New cards

Limited Prescribing Authority

The restricted prescribing scope granted to practitioners such as Dentists (DDS), Optometrists (OD), Podiatrists (DPM), and Veterinarians (DVM), which limits prescribing strictly to conditions within their defined field of practice.

14
New cards

Collaborative Practice Agreement (CPA)

A formal written agreement between prescribers and pharmacists detailing how they will cooperate, coordinate, and consult to allow pharmacists to autonomously provide specific patient care functions.

15
New cards

Holy Trinity

A high-risk controlled substance drug combination consisting of an opioid, a benzodiazepine, and a muscle relaxer (such as oxycodone, alprazolam, and cyclobenzaprine).

16
New cards

Pattern Prescribing

A prescriber red flag involving issuing prescriptions for the exact same controlled drugs and identical quantities across multiple patients.

17
New cards

INSPECT

Indiana's Prescription Drug Monitoring Program (PDMP) database that collects and tracks prescription data for Schedule II–V controlled substances, gabapentin, and ephedrine/pseudoephedrine prescriptions every 24 hours.

18
New cards
<p>Pharmacists' Patient Care Process (PPCP)</p>

Pharmacists' Patient Care Process (PPCP)

A standardized clinical practice process consisting of five essential steps: Collect, Assess, Plan, Implement, and Follow Up (Monitor and Evaluate), surrounded by Person-Centered Care.

19
New cards

Compounding

The process of combining, admixing, diluting, reconstituting, or altering a drug or bulk drug substance to create a customized preparation for a patient.

20
New cards

Active Pharmaceutical Ingredient (API)

The active substance in a pharmaceutical formulation intended to produce direct pharmacological or therapeutic activity.

21
New cards

Quantity Sufficient (qs)

A compounding designation meaning to add a sufficient amount of an ingredient to achieve a desired recipe amount.

22
New cards

qs ad

A compounding instruction directing the preparer to add a sufficient quantity of an ingredient up to a specified total final volume or mass.

23
New cards

Weight/Volume Percentage (% w/v)

A concentration expression defined as the number of grams of active pharmaceutical ingredient in 100 mL100\,\text{mL} of liquid solution or suspension.

24
New cards

Weight/Weight Percentage (% w/w)

A concentration expression defined as the number of grams of active pharmaceutical ingredient in 100 g100\,\text{g} of total solid or semi-solid preparation.

25
New cards

Loading Dose

An initial drug dose, usually larger than maintenance doses, administered as a bolus or series of doses to rapidly reach target drug levels in the blood.

26
New cards

Maintenance Dose

The recurring drug dose administered at set intervals to maintain steady-state therapeutic drug concentrations in the body.

27
New cards

Sentinel Event

An unexpected occurrence in healthcare involving death or serious physical or psychological injury.